{"product_id":"understanding-the-worlds-two-most-important-blood-pressure-guidelines-what-patients-should-know","title":"Understanding the World's Two Most Important Blood Pressure Guidelines: What Patients Should Know","description":"\u003cp\u003eTwo of the world's most influential blood pressure guidelines—the 2017 American College of Cardiology\/American Heart Association (ACC\/AHA) guideline and the 2018 European Society of Cardiology\/European Society of Hypertension (ESC\/ESH) guideline—agree on far more than they disagree. Their most significant difference is the blood pressure threshold used to diagnose hypertension: the American guideline uses 130\/80 mm Hg, while the European guideline retains the traditional 140\/90 mm Hg. Both documents were created through rigorous scientific review, offer extensive recommendations for prevention, diagnosis, and treatment, and their similarities provide a strong foundation for global improvements in blood pressure management.\u003c\/p\u003e\n\n\u003ch1\u003eUnderstanding the World's Two Most Important Blood Pressure Guidelines: What Patients Should Know\u003c\/h1\u003e\n\n\u003ch2\u003eTable of Contents\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#ddn-key-points\"\u003eKey Points\u003c\/a\u003e\u003c\/li\u003e\n\n  \u003cli\u003e\u003ca href=\"#why-it-matters\"\u003eWhy These Guidelines Matter\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#how-developed\"\u003eHow the Guidelines Were Created\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#measurement\"\u003eBlood Pressure Measurement: Getting It Right\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#classification\"\u003eHow Blood Pressure Is Classified\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#evaluation\"\u003eWhat Happens During a Patient Evaluation\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#risk-assessment\"\u003eAssessing Your Heart Disease Risk\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#lifestyle\"\u003eLifestyle Changes: The Foundation of Treatment\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#drug-therapy\"\u003eWhen to Start Blood Pressure Medication\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#clinical-implications\"\u003eWhat This Means for Patients\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#limitations\"\u003eWhat These Guidelines Couldn't Determine\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#recommendations\"\u003eRecommendations for Patients\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#ddn-faq\"\u003eFrequently Asked Questions\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#source\"\u003eSource Information\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003c!-- ddn:keypoints:start --\u003e\n\u003ch2 id=\"ddn-key-points\"\u003eKey Points\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eBoth guidelines agree lifestyle changes are the foundation of prevention and treatment.\u003c\/li\u003e\n\u003cli\u003eThe American threshold for hypertension is 130\/80; the European is 140\/90.\u003c\/li\u003e\n\u003cli\u003eHome blood pressure of 135\/85 or higher corresponds to an office reading of 140\/90.\u003c\/li\u003e\n\u003cli\u003eConfirming office hypertension with home or ambulatory monitoring is recommended by both guidelines.\u003c\/li\u003e\n\u003cli\u003eTreatment decisions depend on overall heart disease risk, not just the blood pressure number.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- ddn:keypoints:end --\u003e\n\n\n\u003ch2 id=\"why-it-matters\"\u003eWhy These Guidelines Matter\u003c\/h2\u003e\n\u003cp\u003eFew areas of medicine offer a better opportunity for making decisions based on sound scientific evidence than the prevention and management of high blood pressure (hypertension). High blood pressure is one of the most common conditions affecting adults worldwide, and it is a major contributor to heart attacks, strokes, kidney failure, and premature death.\u003c\/p\u003e\n\u003cp\u003eThe 2017 ACC\/AHA guideline, developed in partnership with 9 other professional societies, is formally titled the \"\u003cem\u003eGuideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults\u003c\/em\u003e.\" One year later, the European Society of Cardiology and the European Society of Hypertension published the 2018 ESC\/ESH \u003cem\u003eGuidelines for the Management of Arterial Hypertension\u003c\/em\u003e.\u003c\/p\u003e\n\u003cp\u003eTogether, these two documents are among the most cited and influential clinical practice guidelines for blood pressure in the world. This article explains their key recommendations, highlights where they agree and differ, and helps patients understand what the science means for their own care.\u003c\/p\u003e\n\n\u003ch2 id=\"how-developed\"\u003eHow the Guidelines Were Created\u003c\/h2\u003e\n\u003cp\u003eBoth guidelines were built on rigorous scientific methods, though the details of their processes differed. The ACC\/AHA guideline was written by a 21-member committee that included primary care physicians, specialists, epidemiologists, a nurse, a physician assistant, a pharmacist, and two lay\/patient members. Members were chosen for their expertise and their ability to represent the two principal sponsors (ACC and AHA) plus 9 collaborating professional societies. A key requirement for participation was having \u003cstrong\u003eno financial relationships with blood pressure–related commercial entities\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eThe ESC\/ESH guideline was developed by a larger, 28-member committee of physicians and nurses selected from 14 European countries, with half chosen by the ESC and half by the ESH. Unlike the American committee, European members were required to \u003cem\u003edisclose\u003c\/em\u003e (rather than avoid) any industry relationships.\u003c\/p\u003e\n\u003cp\u003eThe ACC\/AHA process mandated systematic reviews and meta-analyses conducted by an independent Evidence Review Committee, plus the creation of \u003cstrong\u003e448 detailed evidence tables\u003c\/strong\u003e to support the recommendations. The ESC\/ESH committee concluded that already-published systematic reviews and meta-analyses provided sufficient evidence, though they had the option to commission additional reviews.\u003c\/p\u003e\n\u003cp\u003eBoth documents underwent extensive peer review and required final approval from the governing boards of their sponsoring organizations. The final products are substantial:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eACC\/AHA guideline:\u003c\/strong\u003e 106 formal recommendations and 103 pages\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eESC\/ESH guideline:\u003c\/strong\u003e 122 formal recommendations and 84 pages\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIn both documents, each recommendation is graded by a \u003cstrong\u003eclass of recommendation\u003c\/strong\u003e (reflecting how strongly it is advised) and a \u003cstrong\u003elevel of evidence\u003c\/strong\u003e (reflecting how solid the supporting science is). Committee members voted on the wording and grading of every single recommendation.\u003c\/p\u003e\n\n\u003ch2 id=\"measurement\"\u003eBlood Pressure Measurement: Getting It Right\u003c\/h2\u003e\n\u003cp\u003eErrors in measuring blood pressure are a major source of misclassification—meaning patients may be incorrectly labeled as having (or not having) hypertension. Both guidelines place strong emphasis on \u003cstrong\u003eusing validated devices and taking multiple readings\u003c\/strong\u003e for accurate diagnosis and management.\u003c\/p\u003e\n\u003cp\u003eThe ACC\/AHA guideline recommends averaging office blood pressure readings, using at least 2 readings on at least 2 separate occasions. It also recommends confirming office-based hypertension with out-of-office measurements (home or ambulatory monitoring) to catch \"white coat hypertension\" (elevated readings only in the doctor's office) and \"masked hypertension\" (normal office readings but elevated readings at home).\u003c\/p\u003e\n\u003cp\u003eThe ESC\/ESH guideline recommends 3 readings for office measurement, with additional readings when the first 2 differ by \u003cstrong\u003e10 mm Hg or more\u003c\/strong\u003e, or when blood pressure is unstable due to an irregular heartbeat. The reading is recorded as the average of the last 2 measurements. It also advises confirming office hypertension either with repeated office readings at several visits or with out-of-office monitoring.\u003c\/p\u003e\n\u003cp\u003eBoth guidelines recommend recording \u003cstrong\u003eheart rate\u003c\/strong\u003e during blood pressure measurements, and the ESC\/ESH considers a resting heart rate above 80 beats per minute to be a cardiovascular risk factor.\u003c\/p\u003e\n\u003cp\u003eTo help patients and doctors interpret home and 24-hour monitor readings, both guidelines provide comparison tables. For example, an office blood pressure of 140\/90 mm Hg corresponds roughly to:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHome readings:\u003c\/strong\u003e 135\/85 mm Hg\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDaytime (awake) ambulatory readings:\u003c\/strong\u003e 135\/85 mm Hg\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNighttime (sleep) readings:\u003c\/strong\u003e 120\/70 mm Hg\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e24-hour average:\u003c\/strong\u003e 130\/80 mm Hg\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe ACC\/AHA provides a full equivalence table ranging from 120\/80 to 160\/100 mm Hg for office readings. The ESC\/ESH provides equivalence values only for the hypertension diagnosis threshold of 140\/90 mm Hg, but these values match the American ones.\u003c\/p\u003e\n\n\u003ch2 id=\"classification\"\u003eHow Blood Pressure Is Classified\u003c\/h2\u003e\n\u003cp\u003eThis is the most obvious difference between the two guidelines. The ACC\/AHA uses a simpler system with 4 categories:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNormal:\u003c\/strong\u003e less than 120\/80 mm Hg\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eElevated:\u003c\/strong\u003e systolic 120–129 mm Hg and diastolic less than 80 mm Hg\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStage 1 hypertension:\u003c\/strong\u003e systolic 130–139 mm Hg \u003cem\u003eor\u003c\/em\u003e diastolic 80–89 mm Hg\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStage 2 hypertension:\u003c\/strong\u003e systolic 140 mm Hg or higher \u003cem\u003eor\u003c\/em\u003e diastolic 90 mm Hg or higher\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe ESC\/ESH uses a more detailed classification with 6 categories:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOptimal:\u003c\/strong\u003e less than 120\/80 mm Hg\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNormal:\u003c\/strong\u003e systolic 120–129 mm Hg and\/or diastolic 80–84 mm Hg\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHigh normal:\u003c\/strong\u003e systolic 130–139 mm Hg and\/or diastolic 85–89 mm Hg\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGrade 1 hypertension:\u003c\/strong\u003e systolic 140–159 mm Hg and\/or diastolic 90–99 mm Hg\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGrade 2 hypertension:\u003c\/strong\u003e systolic 160–179 mm Hg and\/or diastolic 100–109 mm Hg\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGrade 3 hypertension:\u003c\/strong\u003e systolic 180 mm Hg or higher and\/or diastolic 110 mm Hg or higher\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIsolated systolic hypertension:\u003c\/strong\u003e systolic 140 mm Hg or higher with diastolic below 90 mm Hg\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe American change from the older 140\/90 threshold to \u003cstrong\u003e130\/80 mm Hg\u003c\/strong\u003e was a significant departure from the previous 2003 Joint National Committee 7 guideline. Those older guidelines had used the 130\/80 threshold only for patients with diabetes or chronic kidney disease.\u003c\/p\u003e\n\u003cp\u003eThe impact of this reclassification is substantial. Using data from the 2011–2014 National Health and Nutrition Examination Survey (NHANES), researchers estimated:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e24.1%\u003c\/strong\u003e of US adults (age 20+) were already taking antihypertensive medication and therefore considered to have hypertension\u003c\/li\u003e\n  \u003cli\u003eOf those not taking medication, \u003cstrong\u003e7.7%\u003c\/strong\u003e had blood pressure of 140\/90 or higher\u003c\/li\u003e\n  \u003cli\u003eAnother \u003cstrong\u003e13.7%\u003c\/strong\u003e had blood pressure in the 130–139\/80–89 range\u003c\/li\u003e\n  \u003cli\u003eUsing the 130\/80 threshold, the estimated hypertension prevalence in US adults was \u003cstrong\u003e46%\u003c\/strong\u003e, compared to \u003cstrong\u003e32%\u003c\/strong\u003e using the 140\/90 threshold\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis represents an approximately \u003cstrong\u003e14% population increase\u003c\/strong\u003e in the number of adults classified as having hypertension. The difference was most pronounced in younger adults and in men compared to women. It's worth noting that these estimates may be somewhat inflated, since blood pressure was measured on a single occasion and not confirmed with out-of-office readings.\u003c\/p\u003e\n\u003cp\u003eThe ACC\/AHA classification captures more of the blood pressure–related risk for cardiovascular disease, but it creates a greater challenge for doctors: more patients are labeled as having hypertension, and treatment decisions for stage 1 hypertension require assessment of underlying heart disease risk.\u003c\/p\u003e\n\n\u003ch2 id=\"evaluation\"\u003eWhat Happens During a Patient Evaluation\u003c\/h2\u003e\n\u003cp\u003eBoth guidelines recommend that doctors take a thorough personal and family history, perform a physical examination (including blood pressure measurement), and order basic laboratory tests. The recommended tests overlap substantially, with both guidelines requiring:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eFasting blood glucose\u003c\/li\u003e\n  \u003cli\u003eBlood\/serum sodium and potassium\u003c\/li\u003e\n  \u003cli\u003eLipid profile (cholesterol and triglycerides)\u003c\/li\u003e\n  \u003cli\u003eSerum creatinine and estimated glomerular filtration rate (eGFR, a measure of kidney function)\u003c\/li\u003e\n  \u003cli\u003eUrinalysis\u003c\/li\u003e\n  \u003cli\u003eElectrocardiogram (ECG)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe ACC\/AHA additionally recommends a complete blood count, serum calcium, and thyroid-stimulating hormone. The ESC\/ESH additionally recommends hemoglobin\/hematocrit, blood uric acid, glycated hemoglobin A1c (HbA1c, a measure of average blood sugar), liver function tests, and urine protein testing (ideally a urinary albumin-to-creatinine ratio).\u003c\/p\u003e\n\u003cp\u003eThe European guideline places greater emphasis on detecting \u003cstrong\u003ehypertension-mediated organ damage (HMOD)\u003c\/strong\u003e—harm that high blood pressure has already caused to organs like the heart, kidneys, and brain. Their guideline recommends considering echocardiography (ultrasound of the heart), carotid ultrasound, pulse wave velocity, and ankle-brachial index as additional tests to detect HMOD. The ACC\/AHA lists an echocardiogram, uric acid, and urinary albumin-to-creatinine ratio as optional tests.\u003c\/p\u003e\n\n\u003ch2 id=\"risk-assessment\"\u003eAssessing Your Heart Disease Risk\u003c\/h2\u003e\n\u003cp\u003eBoth guidelines agree that assessing a patient's overall cardiovascular disease (CVD) risk is essential for making treatment decisions—it's not just about the blood pressure number itself. However, they use different tools and approaches.\u003c\/p\u003e\n\u003cp\u003eThe \u003cstrong\u003eACC\/AHA\u003c\/strong\u003e approach is relatively straightforward:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eIf a patient already has cardiovascular disease, they are automatically considered \u003cstrong\u003ehigh risk\u003c\/strong\u003e\n\u003c\/li\u003e\n  \u003cli\u003eFor adults age 40–79 without CVD, risk is calculated using the \u003cstrong\u003ePooled Cohort Equations\u003c\/strong\u003e, which estimate the 10-year risk of atherosclerotic cardiovascular disease (ASCVD) events like heart attacks and strokes\u003c\/li\u003e\n  \u003cli\u003eThe risk calculator considers age, systolic and diastolic blood pressure, total cholesterol, HDL (\"good\") cholesterol, LDL (\"bad\") cholesterol, history of diabetes, current smoking status, and use of blood pressure medication, statins, or aspirin\u003c\/li\u003e\n  \u003cli\u003eA 10-year risk of \u003cstrong\u003e10% or higher\u003c\/strong\u003e is considered high risk; below 10% is lower risk\u003c\/li\u003e\n  \u003cli\u003ePatients with diabetes, chronic kidney disease, or age 65+, are automatically considered high risk\u003c\/li\u003e\n  \u003cli\u003eFor adults under 40, the guideline recommends estimating \u003cem\u003elifetime\u003c\/em\u003e CVD risk\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe \u003cstrong\u003eESC\/ESH\u003c\/strong\u003e approach uses four risk categories. Adults with existing cardiovascular disease (including asymptomatic atherosclerosis found on imaging), type 1 or type 2 diabetes, very high individual risk factors (like grade 3 hypertension), or chronic kidney disease are considered \u003cstrong\u003ehigh or very high risk\u003c\/strong\u003e (defined as 10-year CVD mortality of 5–10% and ≥10%, respectively). For everyone else, the guideline recommends using the \u003cstrong\u003eSystematic Coronary Risk Evaluation (SCORE)\u003c\/strong\u003e system, which estimates the 10-year risk of a \u003cem\u003efatal\u003c\/em\u003e cardiovascular event based on age, sex, total cholesterol (or total cholesterol\/HDL ratio), smoking status, and systolic blood pressure.\u003c\/p\u003e\n\u003cp\u003eThe ESC\/ESH guidelines also:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eProvide SCORE charts for both high-risk and low-risk European countries (15 national or regional versions are available)\u003c\/li\u003e\n  \u003cli\u003eInclude correction factors for ethnicity\u003c\/li\u003e\n  \u003cli\u003eEmphasize the importance of HMOD in risk assessment\u003c\/li\u003e\n  \u003cli\u003eUse a classification system that combines blood pressure levels, HMOD, other risk factors, and existing CVD to illustrate how risk multiplies when these factors combine\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eBoth guidelines acknowledge that risk-estimating tools have limitations and can be challenging to use and interpret in everyday practice.\u003c\/p\u003e\n\n\u003ch2 id=\"lifestyle\"\u003eLifestyle Changes: The Foundation of Treatment\u003c\/h2\u003e\n\u003cp\u003eHigh blood pressure in a large percentage of adults is linked to an unhealthy diet, lack of physical activity, and\/or alcohol use. On this point, the two guidelines agree completely: \u003cstrong\u003elifestyle modification is the cornerstone of both prevention and treatment\u003c\/strong\u003e of hypertension.\u003c\/p\u003e\n\u003cp\u003eThe ACC\/AHA guideline recommends:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eA healthy diet, especially the \u003cstrong\u003eDASH diet\u003c\/strong\u003e (Dietary Approaches to Stop Hypertension)\u003c\/li\u003e\n  \u003cli\u003eWeight loss for adults who are overweight or obese\u003c\/li\u003e\n  \u003cli\u003eReducing dietary sodium (salt)\u003c\/li\u003e\n  \u003cli\u003eIncreasing dietary potassium intake\u003c\/li\u003e\n  \u003cli\u003eRegular physical activity\u003c\/li\u003e\n  \u003cli\u003eModeration of, or complete abstinence from, alcohol\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe ESC\/ESH guideline recommends the same core elements, but highlights the \u003cstrong\u003eMediterranean diet\u003c\/strong\u003e as the preferred healthy eating pattern. Both documents recognize that lifestyle change is often difficult, which is why both call on healthcare providers to give patients practical support and follow-up.\u003c\/p\u003e\n\n\u003ch2 id=\"drug-therapy\"\u003eWhen to Start Blood Pressure Medication\u003c\/h2\u003e\n\u003cp\u003eThis is where the two guidelines' differences in blood pressure thresholds translate into different treatment recommendations.\u003c\/p\u003e\n\u003cp\u003eThe \u003cstrong\u003eACC\/AHA\u003c\/strong\u003e guideline recommends starting medication in all adults with blood pressure of \u003cstrong\u003e140\/90 mm Hg or higher\u003c\/strong\u003e, regardless of their cardiovascular risk level. Additionally, it recommends medication for the approximately \u003cstrong\u003e30% of adults with blood pressure in the 130–139\/80–89 range who are identified as high risk\u003c\/strong\u003e (based on the CVD risk assessment described above). This disproportionately affects older patients, since age is such a powerful and unchangeable risk factor.\u003c\/p\u003e\n\u003cp\u003eThe \u003cstrong\u003eESC\/ESH\u003c\/strong\u003e guideline also recommends immediate drug therapy at 140\/90 mm Hg or higher, but only for patients who are at \u003cstrong\u003ehigh or very high risk\u003c\/strong\u003e due to existing cardiovascular disease, kidney disease, or HMOD. For patients at low or moderate risk, the European guideline recommends starting medication only if blood pressure is not controlled after \u003cstrong\u003e3 months of lifestyle intervention\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eFor the \"high normal\" range (130–139\/85–89 mm Hg), the ESC\/ESH recommends drug therapy \u003cem\u003emay\u003c\/em\u003e be considered only in patients with cardiovascular disease, especially coronary artery disease.\u003c\/p\u003e\n\u003cp\u003eOne important exception in the European guideline: adults over \u003cstrong\u003e80 years of age\u003c\/strong\u003e who have untreated hypertension should only be considered for blood pressure–lowering medication when their office systolic blood pressure is \u003cstrong\u003e160 mm Hg or higher\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003ch2 id=\"clinical-implications\"\u003eWhat This Means for Patients\u003c\/h2\u003e\n\u003cp\u003eThe practical takeaway from comparing these two guidelines is that the overall message is consistent: \u003cstrong\u003ehigh blood pressure must be taken seriously, treated early, and managed persistently\u003c\/strong\u003e. Some key implications:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eIf your blood pressure is 130–139\/80–89 mm Hg, the American guideline considers you to have stage 1 hypertension, while the European guideline considers you to have \"high normal\" blood pressure. Both agree that this level warrants attention, particularly lifestyle changes.\u003c\/li\u003e\n  \u003cli\u003eIf your blood pressure is 140\/90 mm Hg or higher, both guidelines agree you should be treated—the only question is whether medication begins immediately or after a short trial of lifestyle changes.\u003c\/li\u003e\n  \u003cli\u003eBoth guidelines strongly encourage home blood pressure monitoring and, where available, 24-hour ambulatory monitoring. This helps catch white coat and masked hypertension.\u003c\/li\u003e\n  \u003cli\u003eOut-of-office readings that correspond to an office reading of 140\/90 mm Hg are 135\/85 mm Hg for home readings and daytime averages, and 130\/80 mm Hg for 24-hour averages.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe authors note that the concordance between the two guidelines is greater than in previous generations of guidelines. They recommend that future guideline committees work to harmonize their recommendations even further, which would \"underscore the commonality of their core recommendations and could serve to catalyze changes in practice that would lead to improved prevention, awareness, treatment, and control of hypertension, worldwide.\"\u003c\/p\u003e\n\n\u003ch2 id=\"limitations\"\u003eWhat These Guidelines Couldn't Determine\u003c\/h2\u003e\n\u003cp\u003eAs with all medical guidelines, both documents have limitations that patients and clinicians should keep in mind:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eThe NHANES-based prevalence estimates for the US likely \u003cstrong\u003eoverestimate\u003c\/strong\u003e true hypertension prevalence because blood pressure was measured on only a single occasion and was not confirmed with out-of-office readings.\u003c\/li\u003e\n  \u003cli\u003eBoth guidelines acknowledge \u003cstrong\u003echallenges with the use and interpretation\u003c\/strong\u003e of CVD\/ASCVD risk-estimating tools, which can limit their accuracy in individual patients.\u003c\/li\u003e\n  \u003cli\u003eBoth guidelines note the \u003cstrong\u003euncertainty\u003c\/strong\u003e in their treatment recommendations for white coat and masked hypertension.\u003c\/li\u003e\n  \u003cli\u003eThe guidelines recommend differing approaches to risk assessment (Pooled Cohort Equations vs. SCORE), which can lead to different risk classifications for the same patient depending on which system is used.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"recommendations\"\u003eRecommendations for Patients\u003c\/h2\u003e\n\u003cp\u003eBased on the harmonized messages from both guidelines, patients can take the following practical steps:\u003c\/p\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eKnow your numbers.\u003c\/strong\u003e Have your blood pressure measured regularly with a validated device, and take readings both in the office and at home.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eGet accurate readings.\u003c\/strong\u003e Sit quietly for several minutes before measurement, avoid caffeine and smoking beforehand, and use a properly sized cuff. Take at least 2–3 readings and record the average.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAdopt a heart-healthy diet.\u003c\/strong\u003e Whether you follow the DASH diet or the Mediterranean diet, the principles are the same: more fruits, vegetables, whole grains, and lean protein; less salt, saturated fat, and processed food.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMove more.\u003c\/strong\u003e Aim for regular physical activity, as recommended by your doctor.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWatch your weight.\u003c\/strong\u003e Weight loss is one of the most effective lifestyle interventions for lowering blood pressure.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLimit alcohol.\u003c\/strong\u003e Moderation or abstinence is recommended.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAsk about your overall risk.\u003c\/strong\u003e Ask your doctor to calculate your 10-year cardiovascular risk score and discuss what it means for your treatment plan.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTake medication as prescribed.\u003c\/strong\u003e If your doctor recommends blood pressure medication, take it consistently. Both guidelines agree that treating high blood pressure saves lives.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003c!-- ddn:faq:start --\u003e\n\u003ch2 id=\"ddn-faq\"\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003ch3\u003eWhat is the difference between the American and European blood pressure guidelines?\u003c\/h3\u003e\n\u003cp\u003eThe main difference is the threshold for diagnosing hypertension. The American guideline uses 130\/80 mm Hg, while the European guideline uses 140\/90 mm Hg. Both agree on lifestyle changes and treating blood pressure of 140\/90 or higher, but they differ on when to start medication for lower readings.\u003c\/p\u003e\n\u003ch3\u003eMy blood pressure is often 135\/85 mm Hg at home. What does that mean?\u003c\/h3\u003e\n\u003cp\u003eA home reading of 135\/85 mm Hg corresponds roughly to an office reading of 140\/90 mm Hg. Both guidelines consider this level hypertension. The American guideline would call it stage 1 hypertension; the European guideline would call it grade 1 hypertension. Lifestyle changes are recommended, and medication may be needed based on your overall risk.\u003c\/p\u003e\n\u003ch3\u003eWhat is white coat hypertension and why does it matter?\u003c\/h3\u003e\n\u003cp\u003eWhite coat hypertension means blood pressure is elevated in the doctor's office but normal at home. Both guidelines recommend confirming an office diagnosis with home or ambulatory monitoring to catch this condition. This helps avoid unnecessary treatment. If you have white coat hypertension, your doctor may monitor you closely rather than start medication immediately.\u003c\/p\u003e\n\u003ch3\u003eWhat tests will I need if I am being evaluated for high blood pressure?\u003c\/h3\u003e\n\u003cp\u003eBoth guidelines recommend fasting blood glucose, kidney function tests (creatinine and eGFR), lipid profile, sodium and potassium, urinalysis, and an electrocardiogram (ECG). The American guideline also adds a complete blood count, calcium, and thyroid-stimulating hormone. The European guideline adds hemoglobin, uric acid, HbA1c, liver tests, and urine albumin-to-creatinine ratio.\u003c\/p\u003e\n\u003ch3\u003eWhen should I start taking blood pressure medication?\u003c\/h3\u003e\n\u003cp\u003eThe American guideline recommends medication for all adults with blood pressure 140\/90 or higher, and for those with 130–139\/80–89 if they are at high risk. The European guideline recommends medication at 140\/90 or higher for high-risk patients, and for lower-risk patients after 3 months of lifestyle changes. For adults over 80, European guidelines consider medication only when systolic is 160 or higher.\u003c\/p\u003e\n\u003ch3\u003eWhat lifestyle changes are most important for lowering blood pressure?\u003c\/h3\u003e\n\u003cp\u003eBoth guidelines emphasize a healthy diet (DASH or Mediterranean), weight loss if overweight, reducing salt, increasing potassium, regular physical activity, and limiting alcohol. These are the foundation of both prevention and treatment. Even if you take medication, lifestyle changes remain important for controlling blood pressure and reducing cardiovascular risk.\u003c\/p\u003e\n\u003ch3\u003eHow is my overall heart disease risk assessed?\u003c\/h3\u003e\n\u003cp\u003eThe American guideline uses the Pooled Cohort Equations to estimate 10-year risk of heart attack or stroke for adults aged 40–79. The European guideline uses the SCORE system, which estimates 10-year risk of fatal cardiovascular events. Both consider existing heart disease, diabetes, kidney disease, and other risk factors. Ask your doctor to calculate your risk score and explain it to you.\u003c\/p\u003e\n\u003c!-- ddn:faq:end --\u003e\n\n\u003ch2 id=\"source\"\u003eSource Information\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eOriginal article title:\u003c\/strong\u003e Harmonization of the American College of\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAuthors:\u003c\/strong\u003e Paul K. Whelton, MB, MD, MSc; Robert M. Carey, MD; Giuseppe Mancia, MD; Reinhold Kreutz, MD; Joshua D. Bundy, PhD, MPH; Bryan Williams, MD\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublication:\u003c\/strong\u003e Circulation, September 13, 2022, Volume 146, pages 868–877. DOI: 10.1161\/CIRCULATIONAHA.121.054602. The article was co-published with permission in the European Heart Journal, the Journal of the American College of Cardiology, and Circulation, and is available under a Creative Commons Attribution Non-Commercial License.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eThis patient-friendly article is based on peer-reviewed research. It is intended for educational purposes and should not replace advice from your healthcare provider. Discuss any questions about your blood pressure or treatment plan with your doctor.\u003c\/em\u003e\u003c\/p\u003e","brand":"DiagnosticDetectives.Com","offers":[{"title":"Default Title","offer_id":47400024932508,"sku":null,"price":0.0,"currency_code":"EUR","in_stock":true}],"url":"https:\/\/diagnosticdetectives.fr\/products\/understanding-the-worlds-two-most-important-blood-pressure-guidelines-what-patients-should-know","provider":"DiagnosticDetectives.Com","version":"1.0","type":"link"}